Aspen flags FY2026 normalized EBITDA up 7%-12% to R 7.46 billion-R 7.81 billion

Reuters2026/08/25 13:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Aspen flagged FY 2026 normalised EBITDA from continuing operations up 7%-12% to R 7.46-7.81 billion.
NHEPS from continuing operations seen up 19%-24% to 784.4-817.4 cents; first-half NHEPS had fallen 25%.
Total-operations NHEPS forecast up 7%-12% to 1,129.8-1,182.6 cents; HEPS expected down 24%-19% to 602-641.6 cents.
EPS expected above 100% to 550-620 cents from -243.9 cents, lifted by R 2.4 billion profit on the APAC divestment.
FY 2026 ended with net cash of about R 0.8 billion following R 0.5 billion buybacks; restructuring costs were R 2.3 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspen Pharmacare Holdings Ltd. published the original content used to generate this news brief via SENS, the regulatory disclosure system operated by the Johannesburg Securities Exchange (JSE) (Ref. ID: S601836), on August 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Aspen flags FY2026 normalized EBITDA up 7%-12% to R 7.46 billion-R 7.81 billion

You may also like

Crypto prices